(PharmaNewsWire.Com, May 16, 2017 ) Cutaneous Squamous Cell Carcinoma (cSCC)- Market Insights, Epidemiology and Market Forecast-2023-7MM report provides an overview of the disease and global market size of the Cutaneous Squamous Cell Carcinoma for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the Incident cases of Cutaneous Squamous Cell Carcinoma from 2013-2023.
Cutaneous Squamous Cell Carcinoma is a keratinocytic or non-melanoma skin cancer. cSCC is considered the second most common human malignancy after basal cell carcinoma (BCC).Actinic keratosis is the premalignant precursor for cSCC and early treatment might reduce patient morbidity. Unlike almost all basal-cell carcinomas, cutaneous squamous cell carcinomas are associated with a substantial risk of metastasis. The prognosis is favorable and only 2-5% of SCC metastasize.
According to DelveInsight, the market size for Cutaneous Squamous Cell Carcinoma of 7MM is estimated to be USD XX Million by 2023 at a CAGR of 6.1% for the forecast period i.e., 2013-2023.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope - The report will help in developing business strategies by understanding the trends shaping and driving the Cutaneous Squamous Cell Carcinoma market.Organize sales and marketing efforts by identifying the best opportunities for Cutaneous Squamous Cell Carcinoma in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan. - To understand the future market competition in the 7MM of Cutaneous Squamous Cell Carcinoma and Insightful review of the key market drivers and barriers. - The report provides historical as well as forecasted epidemiology of Cutaneous Squamous Cell Carcinoma in the 7MM. -To understand the regulatory scenario in major markets - The Report also covers the detailed historical and forecasted Cutaneous Squamous Cell Carcinoma market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
Report Introduction 2 Cutaneous Squamous Cell Carcinoma (cSCC) Market Overview at a Glance 8 7 Major Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) (2013-2023) 8 Total Market Share Distribution of Cutaneous Squamous Cell Carcinoma for 7MM in 2016 9 Total Market Share Distribution of Cutaneous Squamous Cell Carcinoma for 7MM in 2023 9 Introduction 10 Signs and Symptoms 10 Pathophysiology 10 Sub-types of cSCC 12 Risk Factors 13 Staging of cSCC 15 Diagnosis 16 Epidemiology and Patient Population 18 Total number of Incident cases 7MM Countries (2016 & 2023) 19 United States 20 Germany 22 France 23 United Kingdom 25 Spain 27 Italy 28 Japan 30 Treatment Algorithm 32 United States 32 NCCN Guidelines 32 Europe 35 British Association of dermatology (BAD) Guidelines 35 French Dermatology Recommendations Association (aRED) 36 European Dermatology Forum 37 London Cancer Skin Pathway Board 39 National Cancer Institute 40 Unmet Needs 41 Marketed Drugs 42 5-Fluorouracil (5-FU) 42 MOA 42 Study 42 Xeloda 44 MOA 44 Study 44 Cisplatin 45 MOA 45 Study 45 Bleomycin 46 MOA 46 Study 46 Doxorubicin 47 MOA 47 Cetuximab 48 MOA 48 Study 48 Gefitinib 49 MOA 49 Study 49 Cutaneous Squamous Cell Carcinoma (cSCC): Country-Wise Market Analysis 51 Region-Specific Market Distribution and Comparison 51 Overview on Cutaneous Squamous Cell Carcinoma (cSCC) (2016) 52 Overview on Cutaneous Squamous Cell Carcinoma(cSCC) (2023) 53 Global Cutaneous Squamous Cell Carcinoma (cSCC): Market Analysis 54 United States Market Size 55 Europe 56 GermanyMarket Size 56 France Market Size 57 United Kingdom Market Size 58 Spain Market Size 59 Italy Market Size 60 Japan Market Size 61 Market Drivers 62 Market Barriers 62
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
Contact Us 90 State Street, Albany, NY 12207, United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : press@marketresearchhub.com Website : http://www.marketresearchhub.com/
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
